Evidence map›Paper›PMID 22932668›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease.

Brian Madajewski, Brendan F Judy, Anas Mouchli, Veena Kapoor, David Holt, May D Wang, Shuming Nie, Sunil Singhal

Registry-linked trialAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04752137 (Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging), which is not on this map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04752137 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging

TypeinterventionalSponsorMassachusetts General HospitalRan2022 to 2030Enrolled100ConditionsBenign Neoplasm, Malignant NeoplasmArmsIndocyanine green, SPY-PHI
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Brian MadajewskiDepartment of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Brendan F Judy
Anas Mouchli
Veena Kapoor
David Holt
May D Wang
Shuming Nie
Sunil Singhal
Georgia Institute of Technology · USEmory University · USUniversity of Pennsylvania · US

Funding

Tissue and Animal UseU54CA119338 · NCI · EMORY UNIVERSITY · PI SHIN, DONG M · 2005 to 2009
$18.4M
Contrast-Enhanced and Image-Guided Surgery of Lung CancerR01CA163256 · NCI · EMORY UNIVERSITY · PI JO, HANJOONG, SINGHAL, SUNIL · 2011 to 2015
$6.5M
Nanotechnology for Multiplexed and Intraoperative Cancer DetectionRC2CA148265 · NCI · EMORY UNIVERSITY · PI NIE, SHUMING · 2009 to 2010
$2.0M
NCI NIH HHS R01 CA163256NCI NIH HHS RC2 CA148265NCI NIH HHS RC2CA148265NCI NIH HHS U54 CA119338
6 · The paper itself

Abstract

purposeSurgical resection remains the most effective therapy for solid tumors worldwide. The most important prognostic indicator for cure following cancer surgery is a complete resection with no residual disease. However, intraoperative detection of retained cancer cells after surgery is challenging, and residual disease continues to be the most common cause of local failure. We hypothesized that visual enhancement of tumors using near-infrared imaging could potentially identify tumor deposits in the wound after resection. EXPERIMENTAL

designA small animal model of surgery and retained disease was developed. Residual tumor deposits in the wound were targeted using an U.S. Food and Drug Administration-approved imaging agent, indocyanine green, by the enhanced permeability and retention effect. A novel handheld spectrometer was used to optically visualize retained disease after surgery.

resultsWe found residual disease using near-infrared imaging during surgery that was not visible to the naked eye or micro-CT. Furthermore, examination of tumor nodules was remarkably precise in delineating margins from normal surrounding tissues. This approach was most successful for tumors with increased neovasculature.

conclusionsThe results suggest that near-infrared examination of the surgical wound after curative resection can potentially enable the surgeon to locate residual disease. The data in this study is the basis of an ongoing Phase I/II clinical trial in patients who undergo resection for lung and breast cancer.

Indexed as

Diagnostic ImagingIndocyanine GreenNeoplasm, ResidualNeoplasms, ExperimentalAnimalsCell Line, TumorClinical Trials as TopicDogsHumansIntraoperative PeriodMiceNeoplasmsSpectroscopy, Near-InfraredIndocyanine Green

Identifiers

PMID22932668
PMCPMC3482441
OpenAlexW2132668016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.